Article

A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer

Cancer Center, Burnham Institute for Medical Research, La Jolla, CA 92037, USA.
Cancer cell (Impact Factor: 23.89). 11/2008; 14(4):285-98. DOI: 10.1016/j.ccr.2008.09.002
Source: PubMed

ABSTRACT Bcl-2 can be converted into a proapoptotic molecule by nuclear receptor Nur77. However, the development of Bcl-2 converters as anticancer therapeutics has not been explored. Here we report the identification of a Nur77-derived Bcl-2-converting peptide with 9 amino acids (NuBCP-9) and its enantiomer, which induce apoptosis of cancer cells in vitro and in animals. The apoptotic effect of NuBCPs and their activation of Bax are not inhibited but rather potentiated by Bcl-2. NuBCP-9 and its enantiomer bind to the Bcl-2 loop, which shares the characteristics of structurally adaptable regions with many cancer-associated and signaling proteins. NuBCP-9s act as molecular switches to dislodge the Bcl-2 BH4 domain, exposing its BH3 domain, which in turn blocks the activity of antiapoptotic Bcl-X(L).

0 Followers
 · 
176 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The orphan nuclear receptor NR4A1/Nur77/TR3/NGFIB acts primarily as a transcription factor to regulate the expression of multiple genes. However, increasing research attention has recently been given to non-genomic activities of NR4A1. The first description of a non-genomic action of NR4A1 referred to the conversion of anti-apoptotic Bcl-2 into a pro-apoptotic protein by direct interaction with NR4A1. In response to certain apoptotic stimuli, NR4A1 translocates from the nucleus to the mitochondrial outer membrane (MOM) where it associates with Bcl-2 and thereby causes apoptosis. Afterwards, it appeared that NR4A1 could also bind and convert other anti-apoptotic Bcl-2 family members. The latest studies indicate a significant role of NR4A1 in the process of autophagy. For example, a new NR4A1-mediated pathway specific for melanoma cells has been described where NR4A1 interacts with the adenine nucleotide translocase 1 (ANT1) on the mitochondrial inner membrane (MIM) leading to induction of the autophagy pathway. Moreover, NR4A1 interaction with cytoplasmic p53 may also contribute to the induction of autophagy. In addition to mitochondria, NR4A1 could be translocated to the outer membrane of the endoplasmic reticulum (ER) and associate with Bcl-2 or translocon-associated protein subunit γ (TRAPγ) causing ER stress-induced apoptosis. NR4A1 also contributes to the proteasomal degradation of β-catenin in colon cancer cells in vitro and in vivo, as well as to the stabilization of hypoxia-inducible factor-1α (HIF-1α) under non-hypoxic conditions. This review summarizes research findings on non-genomic effects of NR4A1 in normal and cancer cells.
    Steroids 12/2014; 95. DOI:10.1016/j.steroids.2014.12.020 · 2.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The fibroblast mitogen platelet-derived growth factor -BB (PDGF-BB) induces a transient expression of the orphan nuclear receptor NR4A1 (also named Nur77, TR3 or NGFIB). The aim of the present study was to investigate the pathways through which NR4A1 is induced by PDGF-BB and its functional role. We demonstrate that in PDGF-BB stimulated NIH3T3 cells, the MEK1/2 inhibitor CI-1040 strongly represses NR4A1 expression, whereas Erk5 downregulation delays the expression, but does not block it. Moreover, we report that treatment with the NF-κB inhibitor BAY11-7082 suppresses NR4A1 mRNA and protein expression. The majority of NR4A1 in NIH3T3 was found to be localized in the cytoplasm and only a fraction was translocated to the nucleus after continued PDGF-BB treatment. Silencing NR4A1 slightly increased the proliferation rate of NIH3T3 cells; however, it did not affect the chemotactic or survival abilities conferred by PDGF-BB. Moreover, overexpression of NR4A1 promoted anchorage-independent growth of NIH3T3 cells and the glioblastoma cell lines U-105MG and U-251MG. Thus, whereas NR4A1, induced by PDGF-BB, suppresses cell growth on a solid surface, it increases anchorage-independent growth.
    PLoS ONE 09/2014; 9(9):e109047. DOI:10.1371/journal.pone.0109047 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Galectin-3, a member of a large family of animal based β-galactoside-binding lectins has been shown to play a role in a number of cellular and pathogenic processes. This protein has been shown throughout the literature to interact with a diverse multiplicity of proteins, involved in a diverse array of cellular functions, including cell migration and cell proliferation, both of which are of particular in regards to cancer research. Covalent modifications to Galectin-3 that can undermine its binding partner interactions would definitely prove useful in such an enterprise. DX-52-1, a semisynthetic an analog of the natural product quinocarcin, has been shown by the Fenteany Group, to demonstrate remarkable anti-migration and anti-proliferation properties with regard to a number of cancer cell lines. Furthermore this molecule has been shown to bind strongly and specifically to Galectin-3 and Radixin. In the course of this research DX-52-1 has been shown to modestly undermine a number of binding partner interactions of Galectin-3. It has also been demonstrated that the phosphorylation of Galectin-3 also influences its binding to DX-52-1. It has been further demonstrated that DX-52-1 may have an even more potent effect on the formation of higher order complexes that contain Galectin-3. This observation may serve to further explain the strong anti-migration and anti-proliferation effects of DX-52-1. In the course of this work, efforts to map the binding site of DX-52-1 on Galectin-3 were undertaken. In the course of those efforts a novel method to narrow down potential binding sites was developed. Furthermore structure activity relationship studies were performed to determine the importance of certain functional groups on the binding properties of DX-52-1 in regard to Galectin-3 and Radixin as wells as its anti-cellular properties. The results of these SAR studies show a link between the binding of DX-52-1 to Galectin-3 and its anti-migration and anti-proliferation properties.
    12/2014, Degree: Doctor of Philosophy, Supervisor: Gabriel Fenteany and Mark Peczuh

Full-text (2 Sources)

Download
55 Downloads
Available from
May 30, 2014